Home › NDC Lookup › RxCUI directory › RxCUI 1117531

Chloroquine phosphate 250 MG Oral Tablet — RxCUI 1117531

RxNorm drug concept · Semantic clinical drug
RxCUI 1117531 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1117531
Official nameChloroquine phosphate 250 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aschloroquine phosphate 250 MG (eqv to chloroquine 150 MG) Oral Tablet
FDA products mapped2
Package NDCs mapped5
Reported Medicaid activity (SDUD)100 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Chloroquine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Chloroquine Phosphate tablets are used mainly for malaria — either to treat an active infection caused by susceptible strains or to prevent it when you're traveling to a region whe...
  • Follow the schedule your prescriber gave you exactly, because the timing really matters for chloroquine to work properly. For prevention, you take it once a week on the exact same...
  • How do I take this tablet — is there a specific time of day or should I take it with food?
  • Nausea, stomach cramps, headache, itching, and mild blurred vision are among the more common side effects — annoying but usually manageable. The ones to call your doctor about righ...
📖 Read our full Chloroquine guide →

🕸️ Concept Web — How Chloroquine phosphate 250 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Chloroquine phosphate 250 MG Oral Tablet RxCUI 1117531

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Chloroquine 2393
    • Chloroquine phosphate 20863
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Chloroquine Oral Tablet 371407
    • Chloroquine phosphate Oral Tablet 2647790
    • Chloroquine Oral Product 1153861
    • Chloroquine Pill 1153862
    • Chloroquine phosphate Oral Product 2659560
    • Chloroquine phosphate Pill 2662436
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Chloroquine phosphate 250 MG 1117530

Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Chloroquine phosphate 250 MG SCDC · 1117530
  • Chloroquine Oral Tablet SCDF · 371407
  • Chloroquine phosphate Oral Tablet SCDFP · 2647790
  • Chloroquine Oral Product SCDG · 1153861
  • Chloroquine Pill SCDG · 1153862
  • Chloroquine phosphate Oral Product SCDGP · 2659560
  • Chloroquine phosphate Pill SCDGP · 2662436

📦 FDA Products & Package NDCs

2 products · 5 package NDCs
5 package NDCs map to RxCUI 1117531 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00115-2790-02 500 TABLET in 1 BOTTLE (0115-2790-02) Chloroquine Phosphate Amneal Pharmaceuticals of New York LLC 2022-05-10
00115-2790-06 50 TABLET in 1 BOTTLE (0115-2790-06) Chloroquine Phosphate Amneal Pharmaceuticals of New York LLC 2022-05-10
00115-7010-01 100 TABLET in 1 BOTTLE (0115-7010-01) Chloroquine Phosphate Amneal Pharmaceuticals of New York LLC 2022-05-10
00115-7010-02 500 TABLET in 1 BOTTLE (0115-7010-02) Chloroquine Phosphate Amneal Pharmaceuticals of New York LLC 2022-05-10
00115-7010-09 25 TABLET in 1 BOTTLE (0115-7010-09) Chloroquine Phosphate Amneal Pharmaceuticals of New York LLC 2022-05-10
Observed labelers: Amneal Pharmaceuticals of New York LLC (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.